Total trials
142
Active
36
Phase 3
1
Total enrollment
59,894
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Adjunctive Aripiprazole for improving Weight and Metabolic Outcomes in Females | — | — | — | — | — | 1 |
Next readouts
- 2025-03-15
Top conditions
- Type 2 Diabetes Mellitus6
- Physical Inactivity5
- Mental Health Issue5
- Obesity4
- Physical Fitness4
- Metabolic Syndrome3
- Oral Hygiene, Oral Health2
- Migraine2
Frequently asked questions about Universiti Putra Malaysia
- How many clinical trials does Universiti Putra Malaysia have on ClinicalTrials.gov?
- Universiti Putra Malaysia is listed as the lead sponsor on 142 clinical trials in ClinicalTrials.gov, 36 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Universiti Putra Malaysia's trials are in Phase 3?
- 1 of Universiti Putra Malaysia's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Universiti Putra Malaysia focus on?
- Universiti Putra Malaysia's most-studied conditions on ClinicalTrials.gov are Type 2 Diabetes Mellitus, Physical Inactivity, Mental Health Issue, Obesity, Physical Fitness.
- When are Universiti Putra Malaysia's next clinical trial readouts?
- Universiti Putra Malaysia has 1 upcoming primary-completion readout tracked here; the soonest is “Evaluating the Effects of Adjunctive Aripiprazole on Weight and Metabolic Outcomes in Females”, expected around 2025-03-15.